Lifespan extension therapy: Olmesartan, a drug used in the treatment of high blood pressure,  prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 30/August/2017, 11.52 pm

Lifespan extension therapy: Olmesartan, a drug used in the treatment of high blood pressure,  prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 30/August/2017, 11.52 pm

Lifespan extension therapy: Olmesartan, a drug used in the treatment of high blood pressure,  prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 30/August/2017, 11.52 pm 960 720 Dr Boomi's Genom-2-Discovery Center

Significance of the study:

It has been shown earlier that antagonizing angiotensin II type I receptor (AT1R) expression may prolong mammalian life span. Further, it has been shown that disruption of AT1R (AGTR1) gene results in marked prolongation of mammalian lifespan. 

From research findings to therapeutic opportunity: 

This study suggests, for the first time, that Olmesartan, by increasing the expression of its target genes,  it may decrease the expression of AT1R.

Figure1. Mechanistic insights into how Olmesartan functions as a longevity- promoter. Punicalagin, by increasing the expression of its downstream target genes, down regulates A1TR expression and promotes longevity.

And, thereby, it may: (1) decrease blood pressure; (2) decrease blood sugar levels; (3) inhibit pulmonary fibrosis; (4) enhance bacterial immunity; (5) inhibit myocardial infarction; (6) decelerate ageing process; and (4) extend the lifespan of an individual. Thus, pharmacological formulations encompassing “Olmesartan or its analogues, either alone or in combination with other anti-ageing/longevity promoting compounds“ may be used to extend the lifespan of an individual (Figures 1-2).

Price 300[easy_payment currency=”USD”]

Details of the research findings: 

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.  

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How  does Olmesartan  suppress the expression of  angiotensin II type I receptor (AT1R)? 

Amount: $300#

For purchase and payment details, you may reach us at info@genomediscovery.org

#  Research cooperation

References: 

Citation: Boominathan, L.,  Lifespan extension therapy: Olmesartan, a drug used in the treatment of high blood pressure,  prolongs mammalian life span via down regulation of angiotensin II type I receptor (AT1R), 30/August/2017, 11.51 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Share
Molecular-therapy for Regenerating the lost pancreatic β-cells in Diabetic patients: Rivaroxaban (brand name: Xarelto), an anticoagulant drug, increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state via up-regulation of  its target gene Lin28, 30/August/2017, 11.43 pm
Natural product-derived CDK4/6 pathway blockade enhances the efficacy of Cancer immunotherapy: A pharmacological mixture encompassing natural products Berberine, Nimbolide, N-Acetyl-cysteine (BNN) and the anticancer drug Doxorubicin(D) inhibits the expression of cell cycle protein CDK4/CDK6, increases levels of T-III IFNs, inhibits the proliferation of Treg cells, decreases DNMT1 expression, inhibits the expression of a number of immune evasion molecules, increases antigen presentation and unfolding response, increases Cytotoxic activity of T-cells, decreases tumor burden and increases survival via up-regulation of its target genes, 31/August/2017, 1.33 am
Start Typing